Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Chemed Stock Up 1.0%

CHE stock traded up $4.29 during trading on Monday, reaching $426.45. 111,569 shares of the company traded hands, compared to its average volume of 236,435. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $583.96. The business has a 50 day simple moving average of $399.29 and a 200 day simple moving average of $425.94. The company has a market capitalization of $5.66 billion, a price-to-earnings ratio of 23.24, a price-to-earnings-growth ratio of 1.58 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same quarter last year, the company earned $5.63 earnings per share. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Institutional Investors Weigh In On Chemed

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd purchased a new stake in Chemed in the fourth quarter valued at about $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed in the fourth quarter valued at about $26,000. Smartleaf Asset Management LLC raised its stake in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in Chemed in the fourth quarter valued at about $27,000. Finally, First Horizon Corp purchased a new position in shares of Chemed in the third quarter worth about $31,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Royal Bank Of Canada raised their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Wall Street Zen raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Oppenheimer decreased their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Chemed currently has a consensus rating of “Hold” and an average price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.